Inventor · disambiguated record
Joel H. Martin
Also filed as: MARTIN JOEL · MARTIN JOEL H
59 granted patents·22 pending applications·2,264 citations·filing 2001–2025
99Inventor score
Top patents by PatentIndex Score
81 records- 0199US8735095B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2012·Granted May 27, 2014·103 cites·29 claims
- 0299US8043617B2Human antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2009·Granted Oct 25, 2011·91 cites·9 claims
- 0399US7608693B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2008·Granted Oct 27, 2009·158 cites·10 claims
- 0499US7582298B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2007·Granted Sep 1, 2009·390 cites·7 claims
- 0598US9550837B2Therapeutic uses of anti-PCSK9 antibodiesREGENERON PHARMA·Filed 2015·Granted Jan 24, 2017·31 cites·10 claims
- 0698US8501184B2High affinity human antibodies to PCSK9SLEEMAN MARK W·Filed 2010·Granted Aug 6, 2013·76 cites·3 claims
- 0798US8357371B2Methods for treating hypercholesterolemia using antibodies to PCSK9REGENERON PHARMA·Filed 2011·Granted Jan 22, 2013·89 cites·16 claims
- 0898US8062640B2High affinity human antibodies to PCSK9SLEEMAN MARK W·Filed 2009·Granted Nov 22, 2011·237 cites·3 claims
- 0997US9353176B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2013·Granted May 31, 2016·67 cites·13 claims
- 1097US8337839B2High affinity human antibodies to human IL-4 receptorMARTIN JOEL H·Filed 2011·Granted Dec 25, 2012·39 cites·5 claims
- 1197US8309088B2Method of treating osteoarthritis with an antibody to NGFMACDONALD LYNN·Filed 2010·Granted Nov 13, 2012·77 cites·14 claims
- 1297US8075887B2High affinity human antibodies to human IL-4 receptorMARTIN JOEL H·Filed 2009·Granted Dec 13, 2011·42 cites·5 claims
- 1397US7879984B2Human antibodies to human CD20 and method of using thereofREGENERON PHARMA·Filed 2008·Granted Feb 1, 2011·116 cites·4 claims
- 1497US7605237B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2007·Granted Oct 20, 2009·194 cites·6 claims
- 1597US7534868B1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2009·Granted May 19, 2009·38 cites·6 claims
- 1697US7488806B2Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2008·Granted Feb 10, 2009·41 cites·8 claims
- 1796US12269897B2Anti-PCSK9 antibodiesREGENERON PHARMA·Filed 2023·Granted Apr 8, 2025·1 cites·12 claims
- 1896US10941210B2Anti-PCSK9 antibodiesREGENERON PHARMA·Filed 2018·Granted Mar 9, 2021·6 cites·8 claims
- 1996US10023654B2Anti-PCSK9 antibodiesREGENERON PHARMA·Filed 2016·Granted Jul 17, 2018·16 cites·18 claims
- 2096US9884916B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2016·Granted Feb 6, 2018·13 cites·7 claims
- 2196US8148107B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2011·Granted Apr 3, 2012·52 cites·16 claims
- 2296US7988967B2High affinity human antibodies to human nerve growth factorREGENERON PHARMA·Filed 2008·Granted Aug 2, 2011·39 cites·17 claims
- 2395US7919593B2Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2007·Granted Apr 5, 2011·25 cites·22 claims
- 2494US9724411B2Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9REGENERON PHARMA·Filed 2013·Granted Aug 8, 2017·15 cites·32 claims
- 2594US8338135B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2011·Granted Dec 25, 2012·33 cites·12 claims
- 2694US8192741B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2011·Granted Jun 5, 2012·22 cites·10 claims
- 2794US8092802B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2010·Granted Jan 10, 2012·33 cites·4 claims
- 2894US7794717B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2009·Granted Sep 14, 2010·34 cites·4 claims
- 2993US9801362B2Non-human animals expressing pH-sensitive immunoglobulin sequencesREGENERON PHARMA·Filed 2013·Granted Oct 31, 2017·9 cites·43 claims
- 3093US9648856B2Non-human animals expressing pH-sensitive immunoglobulin sequencesREGENERON PHARMA·Filed 2013·Granted May 16, 2017·9 cites·20 claims
- 3193US9475875B2Anti-EGFRvIII antibodies and uses thereofREGENERON PHARMA·Filed 2015·Granted Oct 25, 2016·14 cites·9 claims
- 3293US8637031B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2012·Granted Jan 28, 2014·16 cites·11 claims
- 3393US8613927B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2012·Granted Dec 24, 2013·20 cites·16 claims
- 3493US8568721B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2012·Granted Oct 29, 2013·18 cites·9 claims
- 3593US2025206829A1High affinity antibodies to human il-6 receptorREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3692US8183014B2High affinity antibodies to human IL-6 receptorSTEVENS SEAN·Filed 2011·Granted May 22, 2012·11 cites·19 claims
- 3791US11129903B2Multispecific antigen-binding molecules and uses thereofREGENERON PHARMA·Filed 2016·Granted Sep 28, 2021·8 cites·30 claims
- 3891US10738124B2Anti-EGFRvIII antibodies and uses thereofREGENERON PHARMA·Filed 2018·Granted Aug 11, 2020·3 cites·27 claims
- 3991US9308256B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyREGENERON PHARMA·Filed 2013·Granted Apr 12, 2016·11 cites·14 claims
- 4091US8329181B2Methods for treating B-cell lymphoma by administering an anti-CD20 antibodyMARTIN JOEL H·Filed 2011·Granted Dec 11, 2012·17 cites·4 claims
- 4191US8080248B2Method of treating rheumatoid arthritis with an IL-6R antibodyRADIN ALLEN·Filed 2010·Granted Dec 20, 2011·15 cites·11 claims
- 4287US11191844B2Multispecific antigen-binding molecules and uses thereofREGENERON PHARMA·Filed 2016·Granted Dec 7, 2021·4 cites·31 claims
- 4387US10266588B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2016·Granted Apr 23, 2019·4 cites·29 claims
- 4486US11370843B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·15 claims
- 4586US8097713B2Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereofMARTIN JOEL H·Filed 2010·Granted Jan 17, 2012·8 cites·8 claims
- 4684US8414890B2Human antibodies to human RANKL, encoding nucleic acids and methods of treatmentMARTIN JOEL H·Filed 2009·Granted Apr 9, 2013·12 cites·16 claims
- 4783US2023094591A1High affinity antibodies to human il-6 receptorREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 4880US7615220B2High affinity human antibodies to human IL-18 receptorREGENERON PHARMA·Filed 2007·Granted Nov 10, 2009·3 cites·13 claims
- 4979US2025154286A1Anti-pcsk9 antibodiesREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 5078US8003103B2High affinity human antibodies to human IL-18 receptorREGENERON PHARMA·Filed 2009·Granted Aug 23, 2011·2 cites·15 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joel H. Martin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →